Director Brett Lee Paschke bought 5,000 shares of PRAA at $13.39; stock down 49.8% from 52-week high, post-transaction holdings 30,056 shares.
Director Paschke purchased 5,000 shares at $13.39, increasing his holdings by 20.0% to 30,056 shares. The purchase occurs as the stock trades 49.8% below its 52-week high of $26.77 and has declined 25.5% over the past 30 days and 41.9% over 90 days. His prior buy at PRAA in May 2023 delivered a 90-day return of +1.1%, representing one well-timed purchase at the 90-day mark across his same-ticker history. The company generates $269.6M in quarterly revenue with annual growth of +38.9%, a low P/E of 7.55, and operates at a $533.0M market cap, though net income of $3.7M remains modest relative to revenue. The timing and magnitude of this discretionary purchase against a backdrop of significant recent price declines and company fundamentals warrant attention to whether this represents conviction or reflects other factors.
Director Paschke Brett Lee bought 50,000 shares of DLTH at $1.81 on 2025-04-03, doubling holdings to 93.8K shares
Paschke Brett Lee, a Director, purchased 50,000 shares at $1.81, increasing his holdings by 114.2% from 43.8K to 93.8K shares. The transaction occurred as the stock trades 66.0% below its 52-week high of $4.94 and has declined 39.4% over the prior 30 days and 42.5% over 90 days, suggesting a period of significant market weakness. DLTH's fundamentals remain challenged: the company posted net income of $-28.5M on revenue of $127.1M (latest quarter) and reported annual revenue decline of 3.1% year-over-year, with unprofitability in the most recent full fiscal year. His prior buy at this ticker on 2024-09-04 showed negative returns at both 30 days (-4.3%) and 90 days (-5.3%), indicating prior timing challenges at this specific security.
Director Paschke bought 10,000 shares of DLTH at $3.96 (Sept 2024), doubling stake to 18,959 shares
Director Brett Lee Paschke purchased 10,000 shares at $3.96 on 2024-09-04, increasing his holdings from 8,959 shares to 18,959 shares, a 111.6% increase in his position. The transaction occurred while the stock traded -41.1% from its 52-week high of $6.45 and within its 52-week range of $3.12–$6.45. The company's fundamentals show negative net income of $-3.7M on latest quarterly revenue of $141.6M, with annual revenue contracting -1.0% year-over-year; the firm was unprofitable over its most recent full fiscal year. Paschke's cross-ticker track record shows 1 prior open-market buy with average 90-day return of +1.1% and 100.00% win rate, though this provides limited pattern recognition for DLTH-specific behavior.
